Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients
Wu, A.C.; Mazor, K.M.; Ceccarelli, R.; Loomer, S.; Lu, C.Y. Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients. J. Pers. Med. 2017, 7, 17. https://doi.org/10.3390/jpm7040017
Wu AC, Mazor KM, Ceccarelli R, Loomer S, Lu CY. Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients. Journal of Personalized Medicine. 2017; 7(4):17. https://doi.org/10.3390/jpm7040017
Chicago/Turabian StyleWu, Ann C., Kathleen M. Mazor, Rachel Ceccarelli, Stephanie Loomer, and Christine Y. Lu. 2017. "Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients" Journal of Personalized Medicine 7, no. 4: 17. https://doi.org/10.3390/jpm7040017